Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Olshansky

Showing results (41-50 of 334) with videos related to

Pageof 34
Sort By:
Expert Review of Cardiovascular Therapy|August 4, 2005
Acute anticoagulation adjustment in patients with atrial fibrillation at risk for stroke: approaches, strategies, risks and benefitsBrian Olshansky, Hongsheng Guo
Heartrhythm Case Reports|June 7, 2022
Author's Reply-COVID-19 vaccination and torsades de pointesVictor Abrich, Brian Olshansky
The Physician and Sportsmedicine|February 26, 2014
Increased prevalence of atrial fibrillation in the endurance athlete: potential mechanisms and sport specificityBrian Olshansky, Renee Sullivan
Journal of Cardiovascular Electrophysiology|November 15, 2022
The LEADR ICD lead study: Is thinner better?Christian Anderson, Brian Olshansky
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 18, 2008
Ibutilide revisited: stronger and safer than everRakesh Gopinathannair, Brian Olshansky
Heartrhythm Case Reports|May 17, 2017
An unusual ICD shock: What is the mechanism?Rakesh Gopinathannair, Brian Olshansky
Current Treatment Options in Cardiovascular Medicine|July 11, 2001
SyncopePamela Nerheim, Brian Olshansky
Journal of Cardiovascular Electrophysiology|December 21, 2022
Letter in response to the LEADR ICD lead study: Is thinner better?Christian Anderson, Brian Olshansky
Journal of Atrial Fibrillation|October 7, 2020
Guest EditorialTolga Aksu, Brian Olshansky
Indian Pacing and Electrophysiology Journal|November 10, 2009
Resting sinus heart rate and first degree av block: modifiable risk predictors or epiphenomena?Rakesh Gopinathannair, Brian Olshansky
Pageof 34

Showing results (41-50 of 334) with videos related to

Sort By:
Pageof 34
Expert Review of Cardiovascular Therapy|August 4, 2005
Acute anticoagulation adjustment in patients with atrial fibrillation at risk for stroke: approaches, strategies, risks and benefitsBrian Olshansky, Hongsheng Guo
Heartrhythm Case Reports|June 7, 2022
Author's Reply-COVID-19 vaccination and torsades de pointesVictor Abrich, Brian Olshansky
The Physician and Sportsmedicine|February 26, 2014
Increased prevalence of atrial fibrillation in the endurance athlete: potential mechanisms and sport specificityBrian Olshansky, Renee Sullivan
Journal of Cardiovascular Electrophysiology|November 15, 2022
The LEADR ICD lead study: Is thinner better?Christian Anderson, Brian Olshansky
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 18, 2008
Ibutilide revisited: stronger and safer than everRakesh Gopinathannair, Brian Olshansky
Heartrhythm Case Reports|May 17, 2017
An unusual ICD shock: What is the mechanism?Rakesh Gopinathannair, Brian Olshansky
Current Treatment Options in Cardiovascular Medicine|July 11, 2001
SyncopePamela Nerheim, Brian Olshansky
Journal of Cardiovascular Electrophysiology|December 21, 2022
Letter in response to the LEADR ICD lead study: Is thinner better?Christian Anderson, Brian Olshansky
Journal of Atrial Fibrillation|October 7, 2020
Guest EditorialTolga Aksu, Brian Olshansky
Indian Pacing and Electrophysiology Journal|November 10, 2009
Resting sinus heart rate and first degree av block: modifiable risk predictors or epiphenomena?Rakesh Gopinathannair, Brian Olshansky
Pageof 34